Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies
IntroductionThe prevalent overprescribing of proton pump inhibitors (PPIs) poses health risks from prolonged use. GPs play a key role in initiating deprescribing PPIs, so understanding their decision-making factors and strategies to improve feasibility is crucial. This study aimed to investigate the...
Saved in:
Main Authors: | Nuša Japelj (Author), Lea Knez (Author), Davorina Petek (Author), Nejc Horvat (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Impact of changes in antihypertensive medication on treatment intensity at hospital discharge and 30 days afterwards
by: Nuša Japelj, et al.
Published: (2024) -
Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
by: Sonia Bhardwaj, et al.
Published: (2022) -
Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023) -
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021) -
RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017)